[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2808189B1 - Lipochroman-6 comme inhibiteur de no-synthase et utilisations - Google Patents

Lipochroman-6 comme inhibiteur de no-synthase et utilisations

Info

Publication number
FR2808189B1
FR2808189B1 FR0005520A FR0005520A FR2808189B1 FR 2808189 B1 FR2808189 B1 FR 2808189B1 FR 0005520 A FR0005520 A FR 0005520A FR 0005520 A FR0005520 A FR 0005520A FR 2808189 B1 FR2808189 B1 FR 2808189B1
Authority
FR
France
Prior art keywords
lipochroman
synthase inhibitor
synthase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0005520A
Other languages
English (en)
Other versions
FR2808189A1 (fr
Inventor
Grierson Marie Madeleine Cals
Pascale Pelletier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0005520A priority Critical patent/FR2808189B1/fr
Priority to US10/258,812 priority patent/US7008630B2/en
Priority to JP2001579763A priority patent/JP2003531845A/ja
Priority to PCT/FR2001/001317 priority patent/WO2001082888A1/fr
Priority to EP01929750A priority patent/EP1278509A1/fr
Priority to CA002407334A priority patent/CA2407334A1/fr
Publication of FR2808189A1 publication Critical patent/FR2808189A1/fr
Application granted granted Critical
Publication of FR2808189B1 publication Critical patent/FR2808189B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
FR0005520A 2000-04-28 2000-04-28 Lipochroman-6 comme inhibiteur de no-synthase et utilisations Expired - Fee Related FR2808189B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0005520A FR2808189B1 (fr) 2000-04-28 2000-04-28 Lipochroman-6 comme inhibiteur de no-synthase et utilisations
US10/258,812 US7008630B2 (en) 2000-04-28 2001-04-27 Lipochroman-6 as NO-synthase inhibitor and uses
JP2001579763A JP2003531845A (ja) 2000-04-28 2001-04-27 Ｎｏ合成酵素阻害剤としてのリポクロマン−６とその使用
PCT/FR2001/001317 WO2001082888A1 (fr) 2000-04-28 2001-04-27 Lipochroman-6 comme inhibiteur de no-synthase et utilisations
EP01929750A EP1278509A1 (fr) 2000-04-28 2001-04-27 Lipochroman-6 comme inhibiteur de no-synthase et utilisations
CA002407334A CA2407334A1 (fr) 2000-04-28 2001-04-27 Lipochroman-6 comme inhibiteur de no-synthase et utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0005520A FR2808189B1 (fr) 2000-04-28 2000-04-28 Lipochroman-6 comme inhibiteur de no-synthase et utilisations

Publications (2)

Publication Number Publication Date
FR2808189A1 FR2808189A1 (fr) 2001-11-02
FR2808189B1 true FR2808189B1 (fr) 2004-03-05

Family

ID=8849752

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0005520A Expired - Fee Related FR2808189B1 (fr) 2000-04-28 2000-04-28 Lipochroman-6 comme inhibiteur de no-synthase et utilisations

Country Status (6)

Country Link
US (1) US7008630B2 (fr)
EP (1) EP1278509A1 (fr)
JP (1) JP2003531845A (fr)
CA (1) CA2407334A1 (fr)
FR (1) FR2808189B1 (fr)
WO (1) WO2001082888A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001242502A1 (en) * 2000-03-31 2001-10-15 Henkel Kommanditgesellschaft Auf Aktien Use of protease inhibitors in cosmetics and pharmacy
DE10206664A1 (de) * 2002-02-15 2003-09-04 Henkel Kgaa 6,7-disubstituierte 2,2-Dialkylchromane oder- chromene als Entzündungshemmer
DE10259014A1 (de) * 2002-12-16 2004-06-24 Henkel Kgaa Antioxidans-Kombinationen mit6,7-disubstituierten 2,2-Dialkylchromanen oder-chromenen
US7501136B2 (en) * 2003-09-30 2009-03-10 Kao Corporation Deodorant composition
ES2310142B1 (es) * 2007-06-15 2009-12-04 Lipotec S.A Compuestos reguladores de la pigmentacion.
GB0719202D0 (en) * 2007-10-02 2007-11-07 Boots Co Plc Compositions and methods for the skin and hair
EP2113242A1 (fr) * 2008-05-02 2009-11-04 Pangaea Laboratories Limited Antioxydant destiné à une utilisation dans des préparations cosmétiques, médicamenteuses et pharmaceutiques
FR2934491B1 (fr) * 2008-08-01 2010-09-17 Lvmh Rech Composition cosmetique contenant une association de lipochroman-6 et d'un extrait de logoza et son utilisation
FR2934490B1 (fr) * 2008-08-01 2010-09-17 Lvmh Rech Utilisation dans une composition cosmetique du lipochroman-6 pour ameliorer l'eclat du teint de la peau, notamment du visage
DE102012221079A1 (de) 2012-11-19 2013-08-14 Henkel Ag & Co. Kgaa Verwendung und Mittel zur Verbesserung der Haarstruktur
WO2016131824A1 (fr) * 2015-02-16 2016-08-25 Xantial Composition de prévention ou de traitement d'un trouble cutané
US20180318196A1 (en) * 2015-11-02 2018-11-08 Lubrizol Advanced Materials, Inc. Composition for protecting the skin against the effects of pollution and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03261705A (ja) * 1990-03-09 1991-11-21 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases
ES2072223B1 (es) 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
JPH07316023A (ja) * 1994-05-26 1995-12-05 Shiseido Co Ltd 育毛料
FR2740339B1 (fr) * 1995-10-26 1997-12-05 Oreal Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
WO1998036730A2 (fr) * 1997-02-21 1998-08-27 Beiersdorf Ag Compositions de traitement de l'acne rosacee
DE19711565A1 (de) * 1997-02-21 1998-08-27 Beiersdorf Ag Zubereitungen für die Behandlung von Rosacea
ES2154560B1 (es) * 1998-09-16 2001-12-01 Lipotec Sa Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.
JP2000290177A (ja) * 1999-04-05 2000-10-17 Kanebo Ltd 一酸化窒素捕捉剤及び老化防止化粧料
JP3490658B2 (ja) * 1999-04-19 2004-01-26 カネボウ株式会社 美白化粧料

Also Published As

Publication number Publication date
CA2407334A1 (fr) 2001-11-08
WO2001082888A1 (fr) 2001-11-08
US7008630B2 (en) 2006-03-07
FR2808189A1 (fr) 2001-11-02
JP2003531845A (ja) 2003-10-28
EP1278509A1 (fr) 2003-01-29
US20030165444A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
ATE245142T1 (de) No-synthase inhibitoren
AU3120601A (en) Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
FR2815389B1 (fr) Boite de vitesses
IS6798A (is) Atorvastatínhálfkalsíum form VII
NO20024997D0 (no) 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer
PT102603A (pt) Classificacao de alvos de consumo
ID30187A (id) Dongkrak jenis pantagraf
DE60022980D1 (de) Umgerührte Reibschweissverbindungen enthaltendes Bauelement
FR2825920B1 (fr) Desferal comme inhibiteur de no-synthase et utilisations
PT1272488E (pt) Inibidores de pde4 etanos tri-aril-substituidos
FR2808189B1 (fr) Lipochroman-6 comme inhibiteur de no-synthase et utilisations
DE60136880D1 (de) Kupplungsausrücklager
FR2807128B1 (fr) Boite de vitesses
AU6062901A (en) Ecology access point
FR2810037B1 (fr) Utilisation de derives de 2-aminothiazoline comme inhibiteurs de no-synthase inductible
ATE256662T1 (de) Amorphe modifikation von torasemid
FR2825921B1 (fr) Inhibiteur de no-synthase et utilisations
DE50104376D1 (de) Düngerstreuer
FR2836152B1 (fr) Compositions utiles comme detergents et leurs utilisations
FR2825922B1 (fr) 2-hexadecanoate d'ascorbyle comme inhibiteur de no-synthase et utilisations
FR2825923B1 (fr) Inhibiteur de no-synthase et utilisations
ATE309216T1 (de) Analgetisch wirksame benzosuberonylpiperidin- verbindungen
DE60025274D1 (de) Wässrige acrylbeschichtungszusammensetzung
ATA10302000A (de) Drehelastische kupplung
DE60113686D1 (de) 4,5-dihydro-2-thiazolylaminderivate und ihre verwendung als no-synthase inhibitoren

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081231